Collegium Pharmaceutical prices IPO at $12, the low end of the range – Nasdaq

Collegium Pharmaceutical prices IPO at $12, the low end of the range
Nasdaq
Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, raised $70 million by offering 5.8 million shares at $12, the low end of the range of $12 to $14. Collegium Pharmaceutical plans to list on the

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd